Deep-Dive Due Diligence AI Generated Report on NewGenIvf Group Limited Class A ordinary shares (NIVF)
Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.
These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
NIVF_OUT_1 [2025-04-03 09:39:14 -0400] 2356 Bytes | 621 tokens | Cum: 621 tkns (7.76% of 8k)
==========================================================================
Turbo, you got one job - predict the hottest stocks of the day -- before everyone else does! Ha! So today we're looking at NewGenIvf (NIVF) which is at 1.1 up from 0.589. So, I pulled together a bunch of data for you to look over real fast. It's still early, 9:39:13 AM on Thu Apr 03, 2025 -0400. So, what's the verdict? You're the expert!
--- COMPANY PROFILE ---
Company: NewGenIvf (NIVF)
IPO: IPO date unknown
Shares Outstanding: 1,700,000
Exchange: XNAS
Here's the first list of news for NewGenIvf:
C1 - Today 08:30AM - NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth
C2 - Mar-31-25 09:09AM - NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness
C3 - Mar-07-25 11:30AM - NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive Technology
C4 - Mar-03-25 07:00AM - NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan
C5 - Feb-28-25 07:00AM - NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market
C6 - Feb-20-25 04:30PM - NewGen Issues Clarification on Press Release Titled NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director dated February 20, 2025
C7 - Feb-20-25 04:30PM 06:00AM - NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director
C8 - Jan-31-25 08:00AM - NewGen Announces Reverse Stock Split
ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on NewGenIvf (NIVF)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".
NIVF_IN_2 [2025-04-03 09:39:14 -0400] 2 Bytes | 2 tokens | Cum: 623 tkns (7.79% of 8k)
==========================================================================
C1
NIVF_OUT_3 [2025-04-03 09:39:18 -0400] 1110 Bytes | 299 tokens | Cum: 922 tkns (11.53% of 8k)
==========================================================================
Showing C1 (chunk 1 of 8): C1:
**NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth**
Date: Today 08:30AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/04/03/3055169/0/en/NewGen-Secures-Strategic-Funding-to-Drive-International-Expansion-and-Corporate-Growth.html
April 03, 2025 08:30 ET| Source:NewGenIvf LimitedNewGenIvf Limited
BANGKOK, April 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has secured $5.2 million in strategic funding through two separate arrangements with an investor (“the investor”), with the potential to raise a total of up to $30.8 million through the arrangements. These funding arrangements will provide the necessary capital for N
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
NIVF_IN_4 [2025-04-03 09:39:18 -0400] 299 Bytes | 59 tokens | Cum: 981 tkns (12.26% of 8k)
==========================================================================
NewGenIvf Group Limited, a fertility services provider in Asia, has secured $5.2 million in strategic funding through two arrangements with an investor. The arrangements can potentially raise up to $30.8 million. The funds will be used for the company's international expansion and corporate growth.
NIVF_OUT_5 [2025-04-03 09:39:19 -0400] 1011 Bytes | 280 tokens | Cum: 1261 tkns (15.76% of 8k)
==========================================================================
We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.
A1 - 2025-04-03T12:57:04Z - NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth | Taiwan News...
A2 - 2025-04-03T12:46:24Z - NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth...
A3 - 2025-04-03T12:37:57Z - NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth...
A4 - 2025-03-31T17:05:39Z - 12 Health Care Stocks Moving In Monday's Intraday Session - ABVC BioPharma (NASDAQ:ABVC), bluebird b...
A5 - 2025-03-31T15:51:41Z - Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet - Corcept Therapeutics (NASDAQ:CORT), Mr. ...
Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.
NIVF_IN_6 [2025-04-03 09:39:19 -0400] 2 Bytes | 2 tokens | Cum: 1263 tkns (15.79% of 8k)
==========================================================================
A1
NIVF_OUT_7 [2025-04-03 09:39:23 -0400] 1098 Bytes | 290 tokens | Cum: 1553 tkns (19.41% of 8k)
==========================================================================
Showing A1 (chunk 1 of 8): A1:
**NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth | Taiwan News | Apr. 3, 2025 20:30**Date: 2025-04-03Source: {'uri': 'taiwannews.com.tw', 'dataType': 'news', 'title': 'Taiwan News'}URL: https://taiwannews.com.tw/en/news/6076769Initial focus includes NewGen's expansion into UAE, with further growth initiatives to follow
BANGKOK, April 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has secured $5.2 million in strategic funding through two separate arrangements with an investor ("the investor"), with the potential to raise a total of up to $30.8 million through the arrangements. These funding arrangements will provide the necessary capital for NewGen to
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
NIVF_IN_8 [2025-04-03 09:39:23 -0400] 372 Bytes | 74 tokens | Cum: 1627 tkns (20.34% of 8k)
==========================================================================
NewGenIvf Group Limited, a fertility services provider in Asia, has secured $5.2 million in strategic funding via two separate arrangements with an undisclosed investor. The arrangements potentially offer a total of up to $30.8 million. The initial focus of the funding will be utilized for NewGen's expansion into the UAE, with more growth initiatives expected to follow.
NIVF_OUT_9 [2025-04-03 09:39:30 -0400] 1098 Bytes | 261 tokens | Cum: 1888 tkns (23.60% of 8k)
==========================================================================
Showing A1 (chunk 2 of 8): execute on key growth initiatives, including the establishment of a state-of-the-art fertility clinic in Dubai, United Arab Emirates.
On April 2, 2025, the Company consummated the fourth tranche of its debt financing under the terms of its existing Securities Purchase Agreement with the investor, initially announced in a 6-K filed with the United States Securities and Exchange Commission (the "SEC") on August 16, 2024. At the closing of the fourth tranche, the Company sold to the investor a senior convertible note in the principal amount of $2,000,000. The Note bears an interest rate of 14.75% per annum and may be adjustable from time to time pursuant to its terms.
On April 1, 2025, the Company entered into a new Securities Purchase Agreement with the investor pursuant to which the Company agreed to sell to the investor a senior convertible note in the aggregate original principal amo
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
NIVF_IN_10 [2025-04-03 09:39:30 -0400] 568 Bytes | 107 tokens | Cum: 1995 tkns (24.94% of 8k)
==========================================================================
The company has recently completed the fourth tranche of its debt financing as per its Securities Purchase Agreement with an investor. This tranche involved the sale of a senior convertible note of $2,000,000 with an interest rate of 14.75%. The terms of the note allow for potential adjustments to the interest rate over time. The day before this transaction, the company entered into another Securities Purchase Agreement with the same investor for the sale of an additional senior convertible note. The specific principal amount of this note has not been disclosed.
NIVF_OUT_11 [2025-04-03 09:39:30 -0400] 1042 Bytes | 287 tokens | Cum: 2282 tkns (28.52% of 8k)
==========================================================================
This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!
B1 - 2025-03-31T13:09:46Z - NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness
B2 - 2025-03-07T16:30:02Z - NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive Technology
B3 - 2025-02-28T12:00:00Z - NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market
B4 - 2025-01-31T13:00:00Z - NewGen Announces Reverse Stock Split
B5 - 2025-01-13T11:00:00Z - NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia
B6 - 2024-12-23T12:30:00Z - NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline
Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
NIVF_IN_12 [2025-04-03 09:39:31 -0400] 2 Bytes | 2 tokens | Cum: 2284 tkns (28.55% of 8k)
==========================================================================
B1
NIVF_OUT_13 [2025-04-03 09:39:33 -0400] 735 Bytes | 187 tokens | Cum: 2471 tkns (30.89% of 8k)
==========================================================================
Showing B1 (chunk 1 of 1): B1:
**NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/pressreleases/25/03/g44561461/newgenivf-announces-termination-of-proposed-reverse-merger-transaction-with-european-wellnessNewGenIVF, a fertility services provider in Asia, has terminated its proposed reverse merger transaction with European Wellness Investment Holdings Limited due to the latter's failure to deliver required financial statements by the deadline.
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
NIVF_IN_14 [2025-04-03 09:39:33 -0400] 288 Bytes | 47 tokens | Cum: 2518 tkns (31.47% of 8k)
==========================================================================
NewGenIVF, an Asian fertility services provider, has cancelled its proposed reverse merger transaction with European Wellness Investment Holdings Limited. The termination comes as a result of European Wellness' failure to provide the necessary financial statements by the agreed deadline.
NIVF_OUT_15 [2025-04-03 09:39:34 -0400] 238 Bytes | 59 tokens | Cum: 2577 tkns (32.21% of 8k)
==========================================================================
This is our list of SEC filings.
If empty, the search returned no recent filings.
Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
NIVF_IN_16 [2025-04-03 09:39:34 -0400] 14 Bytes | 3 tokens | Cum: 2580 tkns (32.25% of 8k)
==========================================================================
As a financial
NIVF_OUT_17 [2025-04-03 09:39:43 -0400] 3172 Bytes | 810 tokens | Cum: 3390 tkns (42.38% of 8k)
==========================================================================
This is our set of metrics.
Please analyze the numbers.
+--------------------+-----------------------+-----------------------+-------------------+
| Volume: 0 | Perf Month: -52.88% | Option/Short: No / No | Sales Y/Y TTM: - |
+--------------------+-----------------------+-----------------------+-------------------+
| Avg Volume: 1.22M | Perf Quarter: -92.90% | Short Float: 82.36% | ROE: - |
+--------------------+-----------------------+-----------------------+-------------------+
| Rel Volume: 0.00 | Index: - | Short Ratio: 0.16 | ROI: - |
+--------------------+-----------------------+-----------------------+-------------------+
| RSI (14): 27.49 | Market Cap: 1.00M | Short Interest: 0.19M | Sales Surprise: - |
+--------------------+-----------------------+-----------------------+-------------------+
| ATR (14): 0.28 | Shs Outstand: 14.55M | Beta: 0.17 | EPS Surprise: - |
+--------------------+-----------------------+-----------------------+-------------------+
| SMA20: -40.96% | Shs Float: 0.23M | Sales Q/Q: - | P/E: - |
+--------------------+-----------------------+-----------------------+-------------------+
| SMA50: -73.18% | Inst Own: 0.45% | Sales past 5Y: - | Earnings: - |
+--------------------+-----------------------+-----------------------+-------------------+
| SMA200: -94.88% | Insider Own: 86.27% | Employees: - | |
+--------------------+-----------------------+-----------------------+-------------------+
| Perf Week: -36.74% | Insider Trans: 0.00% | Debt/Eq: - | |
+--------------------+-----------------------+-----------------------+-------------------+
The next section covers any insider trading.
If this section may be blank due to no recent filings.
[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A
[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A
[Price Metrics - Last 30 Days]
Latest Close: 1.25
Average Volume: 2490016.13
30-Day High: 1.77
30-Day Low: 0.589
No detailed financial data available.
==== END OF FINANCIAL REPORT ====
You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.
Now, complete this report with the following:
1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]
1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE
NIVF_IN_18 [2025-04-03 09:39:43 -0400] 950 Bytes | 221 tokens | Cum: 3611 tkns (45.14% of 8k)
==========================================================================
1) Brief Summary: The analysis of this company's financial metrics reveals severe losses over different periods (Perf Month: -52.88%, Perf Quarter: -92.90%, SMA200: -94.88%). There's a high level of short interest (82.36%), and the average volume is 1.22M. However, many data points are missing, such as sales, ROE, ROI, and debt/equity, making it difficult to assess the company's complete financial standing. Insider ownership is high (86.27%), but the institutional ownership is low (0.45%).
2) MARKET_SCORE: Due to the lack of complete financial information and the company's negative performance, it's challenging to calculate an accurate market score. Thus, MARKET_SCORE[N/A]
3) PRICE_TARGET: Given the poor recent performance and lack of available financial information, it isn't prudent to propose a price target. Hence, PRICE_TARGET[N/A].
4) AI_RPT_HEADLINE: "Unknown Company's Financial Turmoil: Complete Analysis Hindered by Data Gaps".
NIVF_OUT_19 [2025-04-03 09:39:45 -0400] 676 Bytes | 167 tokens | Cum: 3778 tkns (47.23% of 8k)
==========================================================================
Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)
NIVF_IN_20 [2025-04-03 09:39:45 -0400] 94 Bytes | 28 tokens | Cum: 3806 tkns (47.58% of 8k)
==========================================================================
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
NIVF_IN_21 [2025-04-03 09:39:45 -0400] 126 Bytes | 29 tokens | Cum: 3835 tkns (47.94% of 8k)
==========================================================================
====================================
[2025-04-03 09:39:45] # Analysis Completed
Elapsed Time: 32.28 seconds